INVESTER I BLS PHARMACEUTICALS MED ENDAVU: Køb BLS Pharmaceuticals ($PR80) aktier gennem Endavu’s investeringsplatform. Hos Endavu kan du købe og sælge aktier i BLS Pharmaceuticals, og handle med aktier, fraktionaler, ETF'er og andre finansielle instrumenter. Endavu tilbyder handel uden kurtage på amerikanske aktier. Endavu tilbyder lav kurtage på tværs af aktier. Handl med over 30.000 forskellige aktier og udenfor markedsåbningstider.

BLS Pharmaceuticals Limited is an Australian pharmaceutical and life sciences company headquartered in Sydney. The company focuses on the manufacture, development, and commercialisation of regulated therapeutic products and active pharmaceutical ingredients across the healthcare sector. Through its wholly owned subsidiary Breathe Life Sciences, BLS Pharmaceuticals operates GMP-licensed facilities that handle medicinal cannabis, psychedelic medicines such as MDMA and psilocybin, and other controlled pharmaceutical products. The group provides pharmaceutical manufacturing, wholesale, distribution, import, export, and contract drug manufacturing services, serving licensed clinics, pharmacies, wholesale distributors, cultivators, active ingredient manufacturers, and pharmaceutical brand sponsors in Australia, Europe, Japan, the United States, and the United Kingdom. In addition to third-party manufacturing, BLS Pharmaceuticals markets own-brand prescription medicines and consumer health products, including cannabinoids, probiotics, novel foods, and wellness supplements, under brands such as Dr Watson and PCC. Founded in 1998 and based in Sydney, Australia, the company plays a specialised role in the regulated therapeutics and consumer health markets.